Placebo lozenges
Sponsors
Ainos, Inc. (f/k/a Amarillo Biosciences Inc., King Abdulaziz University, Sahlgrenska University Hospital, University of Zagreb, University of Helsinki
Conditions
Common ColdCoughDental CariesHalitosisHepatitis C, ChronicOral Mucositis (Ulcerative)PregnancyPulmonary Disease, Chronic Obstructive
Phase 2
Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
TerminatedNCT00690885
Start: 2008-06-30End: 2012-04-30Updated: 2012-04-24
Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C
CompletedNCT00695019
Start: 2009-06-30End: 2012-02-29Updated: 2024-02-21
Phase 3
Phase 4
Consumption Effect of Probiotic Products on Salivary Cariogenic Bacterial Counts in Preschool Children.
NCT02692625
Start: 2015-01-31End: 2016-04-30Target: 160Updated: 2016-02-26
Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis
NCT02789436
Start: 2016-06-30Target: 30Updated: 2016-06-03
Unknown Phase
Lactobacillus Reuteri Feasibility Study on Probiotic Treatment and Perinatal Microbiome
CompletedNCT02693028
Start: 2015-11-30End: 2018-01-31Updated: 2018-12-12
The Effect of Zinc Acetate Lozenges on the Rate of Recovery From the Common Cold
CompletedNCT03309995
Start: 2017-12-01End: 2018-09-24Updated: 2020-02-05